Latest Industry Updates
From company milestones to industry breakthroughs, uncover the stories making waves and shaping the narrative in real time.
- Press Release
Remote monitoring is mitigating the impact of SARS-CoV-2 on clinical trials, marking an acceleration in the...
- Featured Article
The use of direct source data capture in clinical research is on the rise, both during...
Source: Clinical Research News
- Featured Article
The clinical research industry has gone through an important transformation over the past 15 to 20...
Source: ACRP
- Press Release
King of Prussia, PA: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality...
- Featured Article
Poor quality data has the potential to destroy the validity of a clinical trial, wasting precious...
Source: Tufts Center for the Study of Drug Development
- Press Release
KING OF PRUSSIA, PA: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Data Quality...
- Featured Article
Participant safety is the clinical trial sector’s top priority – and striving to achieve this laudable...
Source: Applied Clinical Trials
- Press Release
KING OF PRUSSIA, PA– FDA and its stakeholders have an interest in assuring the integrity of...
- Featured Article
The latest version of the Good Clinical Practice (GCP) quality standard insists that sponsors implement a...
Source: Global Forum
- Press Release
“I KNOW ICH E6 (R2) COMPLIANCE INSISTS ON A RISK-BASED APPROACH TO RUNNING MY TRIALS, BUT...
- Featured Article
A risk-based approach to clinical research may include a central statistical assessment of data quality.
...Source: Sage Journals
- Press Release
Strategic collaboration leverages CluePoints’ Central Statistical Monitoring (CSM) technology to enhance data quality and reduce operational...
- Press Release
King of Prussia, PA – January 12, 2026 – CluePoints, provider of leading statistical and AI-driven...
- Press Release
CluePoints Scoops Prestigious 2025 Scrip Award RBQM and AI leader wins the ‘Best Contract Research Organization...
- Press Release
King of Prussia, PA – November 5th, 2025: CluePoints, provider of leading statistical and AI-driven software...
- Press Release
The RBQM and AI leader wins the ‘Clinical Data Science Implementation Excellence Award’ at SCDM 2025...
- Press Release
KING OF PRUSSIA, Pa., Sept. 23, 2025 /PRNewswire/ — CluePoints, the premier sponsor of RBQMLive and...
- Press Release
RBQM and AI leader was shortlisted for its Time Similarity Test in the ‘Innovative Clinical Trial...
- Press Release
King of Prussia, PA – April 1st, 2025: CluePoints, provider of leading statistical and AI-driven software...
- Press Release
The Company, along with its Research and Development Teams, were shortlisted for continuing its mission of...
- Press Release
CluePoints Appoints Richard Young as Chief Strategy Officer King of Prussia, PA – October 28th, 2024:...
- Press Release
King of Prussia, PA – October 23rd, 2024: CluePoints, provider of leading statistical and AI-driven software...
- Press Release
CluePoints furthers its commitment to delivering innovative solutions that enhance clinical trial efficiency with this latest...
- Press Release
Site Profile & Oversight Tool (SPOT) and Intelligent Medical Coding (IMC) unveiled by RBQM innovator at...
- Featured Article
Clinical trials are undergoing a period of change. Innovative uses of artificial intelligence (AI) are unlocking...
Source: Applied Clinical Trials
- Featured Article
Safety reporting is a critical aspect of clinical trial quality, directly impacting patient safety and regulatory...
Source: Applied Clinical Trials
- Featured Article
In clinical trials, every second counts, both for patient outcomes and sponsor ROI. As data volumes...
Source: Clinical Research News
- Featured Article
The theme for this year’s International Women’s Day (IWD) on 8th March was ‘Give to Gain’....
Source: Pharmaphorum
- Featured Article
Quality tolerance limits (QTLs) are trial-level thresholds on critical-to-quality (CtQ) factors—key measures where sustained deviation could...
Source: Applied Clinical Trials
- Featured Article
Risk-based quality management (RBQM) is becoming central to clinical trial oversight, with ICH E6(R3) emphasising proportional,...
Source: Discover Pharma
- Featured Article
Analysis of more than 880 clinical trials shows that while statistical data monitoring and key risk...
Source: Applied Clinical Trials
- Featured Article
As AI finds solid footing in pharma R&D, the technology is slated to yield significant rewards....
Source: PharmaVoice
- Featured Article
To kick off 2026, we spoke with industry experts and leaders in the Clinical Research News...
Source: Clinical Research News
- Featured Article
Dan Beaudry, market owner for risk-based quality management (RBQM) at CluePoints, explains how regulatory shifts and...
Source: Discover Pharma
- Featured Article
Returning to the series is CluePoints, with Sophie Henderson, senior strategic consultant, sharing her hopes and...
Source: Discover Pharma
- Featured Article
Regulatory changes, including the launch of ICH E6(R3) and Good Clinical Practice (GCP) updates, have highlighted...
Source: International Pharmaceutical Industry
